After its latest pipeline clear-out, Merck KGaA is no longer pursuing any clinical-stage cancer candidates obtained through ...

After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S.

Merck KGaA forecast a sluggish year ahead, with the possibility of falling profits, as generic competition for its multiple ...

Merck KGaA (MKGAF) stock drops as the company projects a disappointing revenue and adjusted EBITDA outlook for 2026. Read more here.

The company anticipates currency headwinds would continue to weigh on its earnings this year, as the life-sciences and ...

Q4 2025 Press Conference Call March 5, 2026 4:00 AM ESTCompany ParticipantsAxel LoberBelén Garijo López - Chair of Executive Board ...

Add Yahoo as a preferred source to see more of our stories on Google. Merck KGaA's antibody-drug conjugate (ADC) Merck KGaA's antibody-drug conjugate (ADC), precemtabart tocentecan (Precem-TcT), has ...

Merck KGaA expects its 2026 adjusted operating profit to decrease by up to 4%, excluding currency effects, according to its latest statement.

Despite a rocky start to the year for Merck KGaA’s contract development and manufacturing group, the German company is finding some reason to be optimistic about its recent performance. Last week, ...

Through its U.S. and Canada life science business MilliporeSigma, Merck KGaA is acquiring Dutch company HUB Organoids. The deal is expected to be finalized by the end of 2024, according to a Dec. 17 ...

The philanthropic arm of Merck KGaA, Merck Foundation, has marked International Women’s Day with renewed commitment to ...

By Samira Larbie Accra, March 12, GNA – Merck Foundation, the philanthropic arm of Merck KGaA, Germany, in commemoration of the International Women’s Day (IWD) 2026, has renewed its commitment to ...